Photochemistry and Photobiology, 2001, 73(5) 467
sion shown by the protein fraction after filtration unequiv-
ocally demonstrated the covalent photobinding of HTB to
the protein.
CONCLUSIONS
HTB, the major metabolite of triflusal, has been found to be
photolabile. Steady-state photolysis indicates that the main
photodegradation pathway is the nucleophilic substitution of
fluoride by the solvent. Photophysical studies (fluorescence
and laser-flash photolysis) unequivocally support the in-
volvement of HTB triplet state in the photodegradation
mechanism.
The covalent photobinding of HTB to a model protein
such as BSA has been demonstrated using fluorescence spec-
troscopy. Nucleophilic groups of the protein (–OH, –SH and
Figure 6. Fluorescence spectra of mixtures HTB–BSA irradiated
and nonirradiated, before and after Sephadex filtration.
–
NH ) are likely responsible for the observed photobinding,
2
which is the first step in the onset of photoallergy.
tobinding to proteins. It is reasonable to think that if nucle-
ophilic solvents are able to attack the trifluoromethyl moiety
of HTB, nucleophilic groups of a protein (such as –OH,
Acknowledgements This work has been sponsored by the European
Union (BMH-4-97-2590). M.L.M. acknowledges Generalitat Val-
enciana for a grant (GV.DOC00-25-02) and M.C.C. thanks Funda-
ci o´ n Jose y Ana Royo for financial support.
–
SH, –NH ) could be able to attack HTB in the same way,
2
resulting in a covalent photobinding to the protein
Scheme 2). This would lead to the formation of a pho-
(
toantigen, which is the first step of a photoallergic reac-
tion.
REFERENCES
1
2
3
. Miranda, M. A. (1997) Phototoxicity of drugs. In In Vitro Meth-
ods in Pharmaceutical Research (Edited by J. V. Castell and
M. J. Gomez-Lechon), pp. 289–315. Academic Press, London.
. Gould, J. W., M. G. Mercurio and C. A. Elmets (1995) Cuta-
neous photosensitivity diseases induced by exogenous agents. J.
Am. Acad. Dermatol. 33, 551–573.
. Ophaswongse, S. and H. Maibach (1993) Topical nonsteroidal
anti-inflammatory drugs: allergic and photoallergic contact der-
matitis and phototoxicity. Contact Dermatitis 29, 57–64.
. Epstein, J. H. (1983) Phototoxicity and photoallergy in man. J.
Am. Acad. Dermatol. 8, 141–147.
A usual test for photobinding involves monitoring of the
UV–Vis absorption changes upon irradiation of a drug–pro-
tein mixture and subsequent isolation of the protein by gel-
filtration chromatography (23,24). This technique allows the
detection of the presence of the drug chromophore. How-
ever, if the drug has a fluorescent chromophore this fact
could be used to test photobinding with a higher sensitivity
(
25).
4
5
Ϫ
Ϫ
Solutions of HTB (6
ϫ
10 5 M) and BSA (4 10 5 M)
ϫ
. Miranda, M. A., J. V. Castell, Gomez-Lechon, M. J., D. Her-
nandez and L. A. Martinez (1995) Photobinding of drugs to cells
as an indicator of potential photoallergy. Toxicol. In Vitro 9,
were irradiated under usual conditions for 20 min. The ab-
sorption spectra of the HTB–BSA mixture before and after
irradiation, prior to and after Sephadex filtration were re-
corded. Although some changes in the UV–Vis spectra were
observed, it was not enough to draw a clear conclusion, since
the drug absorption maximum is relatively close to the pro-
tein absorption bands. But, fluorescence measurements pro-
vided clear evidence for drug–protein photobinding (see Fig.
4
99–503.
6. Miranda, M. A., J. V. Castell, D. Hernandez, M. J. Gomez-
Lechon, F. Bosca, I. M. Morera and Z. Sarabia (1998) Drug
photosensitized protein modification: identification of the reac-
tive sites and elucidation of the reaction mechanism with tia-
profenic acid/albumin as a model system. Chem. Res. Toxicol.
1
1, 172–177.
6
). The emission maximum of the fluorescence spectrum of
7. Miranda, M. A., J. V. Castell, D. Hernandez, M. J. Gomez-
Lechon, I. M. Morera and Z. Sarabia (1999) An in vitro ap-
proach to drug photoallergy: use of drug-directed antibodies to
asses photobinding of non-steroidal anti-inflamatories to skin
cells. Toxicol. In Vitro 13, 701–75.
8. Miranda, M. A., J. V. Castell, Z. Sarabia, D. Hernandez, I. Puer-
tes, I. M. Morera and M. J. Gomez-Lechon (1997) Mechanism
of photosensitization by drugs. Involvement of tyrosines in the
photomodification of proteins mediated by tiaprofenic acid in
vitro. Toxicol. In Vitro 11, 653–659.
mixtures before and after irradiation was somewhat differ-
ent. This is due to the fluorescence of HTB (max 408 nm)
before irradiation and photoproduct-like chromophore (max
4
25 nm) after irradiation.
An important difference was observed between the fluo-
rescence of nonirradiated HTB–BSA mixtures prior to and
after Sephadex filtration. The fluorescence observed for the
mixture before Sephadex treatment is due to the metabolite,
which practically disappears when the sample is filtered
through Sephadex due to the complete removal of HTB from
the mixture. The same was observed when HTA was used
instead of HTB in this control experiment (data not shown).
This rules out the possibility that HTB and/or its photoprod-
uct, HTA, are tightly bound to BSA and may not be removed
by passage through Sephadex.
9
. Serrano, G., A. Aliaga and I. Planells (1987) Photosensitivity
associated with triflusal. Photodermatology 4, 103–105.
1
1
0. Gardeazabal, J., X. Eizaguirre, M. J. Calderon and J. L. Diaz
Perez (1990) Fotodermatitis liquenoide inducida por triflusal
GEF 1, 6.
1. Lee, A. Y., S. H. Yoo and K. H. Lee (1999) A case of photo-
allergic drug eruption caused by triflusal (Disgren). Photoder-
matol. Photoimmunol. Photomed. 15, 85–86.
2. Miranda-Romero, A. and L. Navarro (1992) Fotosensibilidad
por triflusal GEF 5, 31.
3. Messa, G. L., M. Franchi, A. Auteri and T. Diperri (1993) Ac-
tion of 2-acetoxy-trifluoromethylbenzoic acid (triflusal) on
platelet-function after repeated oral-administration in man- A
1
1
After irradiation the fluorescence emission at 425 nm re-
mained the same before and after filtration, indicating that
HTB photodegradation had occurred. The fluorescence emis-